AZELASTINE

AZELASTINE was reported 18655 times

These side effects are most commonly reported by patients taking AZELASTINE:

# Side effect Count
0 TREATMENT FAILURE 1879
1 DRUG INEFFECTIVE 1298
2 FATIGUE 1293
3 PRODUCT DOSE OMISSION ISSUE 1053
4 HEADACHE 995
5 NAUSEA 984
6 DYSPNOEA 965
7 DIARRHOEA 857
8 PAIN 856
9 COUGH 847
10 SINUSITIS 736
11 DIZZINESS 703
12 ASTHMA 622
13 OFF LABEL USE 602
14 PNEUMONIA 595
15 ARTHRALGIA 594
16 PRURITUS 560
17 RASH 557
18 FALL 546
19 COVID-19 524
20 ASTHENIA 484
21 MALAISE 484
22 NO ADVERSE EVENT 455
23 VOMITING 452
24 ANXIETY 426
25 PRODUCT USE IN UNAPPROVED INDICATION 423
26 CONDITION AGGRAVATED 406
27 NASOPHARYNGITIS 401
28 INSOMNIA 395
29 INJECTION SITE PAIN 381
30 BACK PAIN 380
31 WEIGHT DECREASED 370
32 PYREXIA 366
33 CONSTIPATION 364
34 PAIN IN EXTREMITY 357
35 URINARY TRACT INFECTION 357
36 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 341
37 PRODUCT DELIVERY MECHANISM ISSUE 339
38 DEATH 328
39 HYPERSENSITIVITY 328
40 INFECTION 322
41 FEELING ABNORMAL 315
42 DEPRESSION 311
43 ILLNESS 303
44 BRONCHITIS 300
45 WEIGHT INCREASED 294
46 MUSCLE SPASMS 285
47 SOMNOLENCE 284
48 PERIPHERAL SWELLING 271
49 PRODUCT USE ISSUE 265
50 BLOOD PRESSURE INCREASED 264
51 DECREASED APPETITE 264
52 NASAL CONGESTION 257
53 ABDOMINAL PAIN UPPER 243
54 RHINORRHOEA 239
55 ABDOMINAL DISCOMFORT 238
56 GAIT DISTURBANCE 238
57 OROPHARYNGEAL PAIN 238
58 HYPERTENSION 235
59 CHRONIC KIDNEY DISEASE 232
60 INFLUENZA 229
61 MIGRAINE 220
62 CHEST PAIN 219
63 URTICARIA 219
64 CHEST DISCOMFORT 215
65 UPPER RESPIRATORY TRACT INFECTION 213
66 MYALGIA 211
67 GASTROOESOPHAGEAL REFLUX DISEASE 209
68 PRODUCTIVE COUGH 207
69 DRUG HYPERSENSITIVITY 206
70 VISION BLURRED 206
71 ERYTHEMA 204
72 WHEEZING 204
73 DEVICE MALFUNCTION 202
74 MEMORY IMPAIRMENT 198
75 HYPOTENSION 195
76 CONTUSION 193
77 EPISTAXIS 191
78 ABDOMINAL PAIN 189
79 HYPOAESTHESIA 187
80 EYE PAIN 186
81 DRY EYE 183
82 DEHYDRATION 182
83 CHILLS 180
84 SEASONAL ALLERGY 180
85 DRY SKIN 179
86 INCORRECT DOSE ADMINISTERED 177
87 TREMOR 176
88 EYE IRRITATION 174
89 RENAL FAILURE 173
90 ANAEMIA 170
91 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 169
92 PARAESTHESIA 167
93 ABDOMINAL DISTENSION 165
94 HOSPITALISATION 163
95 HEART RATE INCREASED 161
96 OEDEMA PERIPHERAL 159
97 SINUS DISORDER 157
98 ALOPECIA 156
99 DEVICE ISSUE 156
100 SURGERY 155
101 EAR INFECTION 154
102 IMPAIRED QUALITY OF LIFE 153
103 PALPITATIONS 152
104 DRY MOUTH 151
105 SLEEP DISORDER 151
106 THROAT IRRITATION 146
107 INJECTION SITE ERYTHEMA 145
108 NEUROPATHY PERIPHERAL 143
109 ACUTE KIDNEY INJURY 142
110 DYSGEUSIA 142
111 DYSPHONIA 140
112 JOINT SWELLING 138
113 HYPERHIDROSIS 136
114 THERAPY INTERRUPTED 136
115 VISUAL IMPAIRMENT 136
116 INFUSION SITE PAIN 135
117 CEREBROVASCULAR ACCIDENT 132
118 SWELLING 131
119 OXYGEN SATURATION DECREASED 130
120 ARTHRITIS 129
121 DERMATITIS ATOPIC 129
122 MUSCULAR WEAKNESS 129
123 BALANCE DISORDER 128
124 ACCIDENTAL EXPOSURE TO PRODUCT 125
125 INJECTION SITE SWELLING 124
126 ATRIAL FIBRILLATION 123
127 ECZEMA 123
128 CONFUSIONAL STATE 122
129 DYSPEPSIA 122
130 HOT FLUSH 121
131 INFUSION RELATED REACTION 120
132 EMOTIONAL DISTRESS 119
133 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 118
134 DYSPNOEA EXERTIONAL 117
135 FLUSHING 116
136 GASTROINTESTINAL DISORDER 116
137 NECK PAIN 116
138 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 115
139 DYSPHAGIA 114
140 CATARACT 113
141 PSORIASIS 112
142 EYE PRURITUS 111
143 INJECTION SITE BRUISING 111
144 SNEEZING 111
145 MULTIPLE ALLERGIES 110
146 RESPIRATORY TRACT INFECTION 110
147 INFUSION SITE ERYTHEMA 107
148 INTENTIONAL PRODUCT USE ISSUE 104
149 STRESS 104
150 WHITE BLOOD CELL COUNT DECREASED 104
151 DEVICE BREAKAGE 103
152 PRODUCT QUALITY ISSUE 103
153 BLOOD GLUCOSE INCREASED 102
154 CARDIAC DISORDER 102
155 VIRAL INFECTION 102
156 LOSS OF CONSCIOUSNESS 100
157 OCULAR HYPERAEMIA 100
158 SEIZURE 100
159 SKIN EXFOLIATION 100
160 INFUSION SITE SWELLING 99
161 THROMBOSIS 98
162 HERPES ZOSTER 96
163 NEPHROLITHIASIS 96
164 PLATELET COUNT DECREASED 93
165 UPPER-AIRWAY COUGH SYNDROME 93
166 SEPSIS 92
167 BONE PAIN 91
168 PRODUCT DOSE OMISSION IN ERROR 91
169 SLEEP APNOEA SYNDROME 91
170 FLATULENCE 90
171 HAEMOGLOBIN DECREASED 90
172 SWELLING FACE 89
173 INJECTION SITE REACTION 88
174 FLUID RETENTION 87
175 HAEMORRHAGE 87
176 INJECTION SITE PRURITUS 87
177 VERTIGO 87
178 HALLUCINATION 86
179 RHEUMATOID ARTHRITIS 86
180 UNEVALUABLE EVENT 86
181 BLOOD PRESSURE DECREASED 85
182 OEDEMA 85
183 TINNITUS 85
184 ADVERSE DRUG REACTION 83
185 LACRIMATION INCREASED 83
186 DISCOMFORT 82
187 BURNING SENSATION 81
188 MUSCULOSKELETAL STIFFNESS 81
189 DEVICE LEAKAGE 80
190 INSURANCE ISSUE 80
191 INFLUENZA LIKE ILLNESS 79
192 OSTEOARTHRITIS 79
193 DRUG DOSE OMISSION 78
194 ANAPHYLACTIC REACTION 77
195 RASH PRURITIC 77
196 SYNCOPE 77
197 DRUG INTOLERANCE 76
198 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 76
199 THERAPY CESSATION 76
200 SINUS CONGESTION 75
201 FUNGAL INFECTION 74
202 OSTEOPOROSIS 74
203 PRODUCT DOSE OMISSION 74
204 DISEASE PROGRESSION 73
205 EXPOSURE VIA SKIN CONTACT 73
206 PRODUCT SUBSTITUTION ISSUE 73
207 THERAPEUTIC RESPONSE UNEXPECTED 72
208 INFUSION SITE HAEMORRHAGE 71
209 LIMB INJURY 71
210 MOBILITY DECREASED 71
211 INTENTIONAL DOSE OMISSION 70
212 AMNESIA 69
213 DEVICE DEFECTIVE 69
214 GASTROENTERITIS VIRAL 69
215 PRODUCT LEAKAGE 69
216 RESPIRATORY TRACT CONGESTION 69
217 STOMATITIS 69
218 CELLULITIS 68
219 CYSTITIS 68
220 POLLAKIURIA 68
221 CARDIAC FAILURE CONGESTIVE 67
222 PULMONARY EMBOLISM 67
223 TRANSIENT ISCHAEMIC ATTACK 67
224 NASAL DISCOMFORT 66
225 EYE SWELLING 65
226 TACHYCARDIA 65
227 THERAPEUTIC RESPONSE SHORTENED 65
228 LUNG DISORDER 64
229 PRODUCT ADMINISTRATION INTERRUPTED 64
230 THERAPEUTIC RESPONSE DECREASED 64
231 DRUG INTERACTION 63
232 RENAL IMPAIRMENT 63
233 SUICIDAL IDEATION 63
234 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 63
235 ANHEDONIA 62
236 DISEASE RECURRENCE 62
237 IMPAIRED GASTRIC EMPTYING 62
238 INTERVERTEBRAL DISC PROTRUSION 62
239 NERVOUSNESS 62
240 RASH ERYTHEMATOUS 62
241 BLOOD POTASSIUM DECREASED 61
242 INTENTIONAL PRODUCT MISUSE 61
243 ORAL HERPES 61
244 DIABETES MELLITUS 60
245 MYOCARDIAL INFARCTION 60
246 PSORIATIC ARTHROPATHY 59
247 ARTHROPATHY 58
248 DERMATITIS CONTACT 58
249 EYE DISORDER 58
250 HYPOACUSIS 58
251 BLOOD CHOLESTEROL INCREASED 57
252 END STAGE RENAL DISEASE 57
253 INFUSION SITE PRURITUS 57
254 STAPHYLOCOCCAL INFECTION 57
255 EAR PAIN 56
256 HYPOXIA 56
257 MIDDLE INSOMNIA 56
258 RASH MACULAR 56
259 ROAD TRAFFIC ACCIDENT 56
260 THERAPY NON-RESPONDER 56
261 DISTURBANCE IN ATTENTION 55
262 DIVERTICULITIS 55
263 ILL-DEFINED DISORDER 55
264 INFUSION SITE DISCHARGE 55
265 THROAT TIGHTNESS 55
266 BRAIN FOG 54
267 DEPRESSED MOOD 54
268 FIBROMYALGIA 54
269 GASTROINTESTINAL HAEMORRHAGE 54
270 PRODUCT PACKAGING QUANTITY ISSUE 54
271 PRODUCT STORAGE ERROR 54
272 PRODUCT TASTE ABNORMAL 54
273 RESPIRATORY DISORDER 54
274 SKIN DISCOLOURATION 54
275 SPEECH DISORDER 54
276 BLISTER 53
277 CONJUNCTIVITIS 53
278 INFUSION SITE BRUISING 53
279 RED BLOOD CELL COUNT DECREASED 53
280 PRE-EXISTING CONDITION IMPROVED 52
281 FEELING HOT 51
282 HIATUS HERNIA 51
283 INFLAMMATION 51
284 INJECTION SITE RASH 51
285 MULTIPLE SCLEROSIS RELAPSE 51
286 HEART RATE DECREASED 50
287 NIGHT SWEATS 50
288 RENAL DISORDER 50
289 AGEUSIA 49
290 HYPERSOMNIA 49
291 IRRITABILITY 49
292 LETHARGY 49
293 PRODUCT ODOUR ABNORMAL 49
294 PRODUCT USE COMPLAINT 49
295 GAIT INABILITY 48
296 HEREDITARY ANGIOEDEMA 48
297 KIDNEY INFECTION 48
298 PLEURAL EFFUSION 48
299 PULMONARY MASS 48
300 SECRETION DISCHARGE 48
301 SKIN DISORDER 48
302 WHITE BLOOD CELL COUNT INCREASED 48
303 APHONIA 47
304 BLOOD SODIUM DECREASED 47
305 CHRONIC SINUSITIS 47
306 COGNITIVE DISORDER 47
307 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47
308 FOOT FRACTURE 47
309 HEAD INJURY 47
310 PHARYNGITIS STREPTOCOCCAL 47
311 TASTE DISORDER 47
312 ADVERSE EVENT 46
313 HAEMOPTYSIS 46
314 IRRITABLE BOWEL SYNDROME 46
315 AGITATION 45
316 BLOOD GLUCOSE DECREASED 45
317 BLOOD PRESSURE ABNORMAL 45
318 CANDIDA INFECTION 45
319 HEPATIC ENZYME INCREASED 45
320 NEEDLE ISSUE 45
321 NEURALGIA 45
322 NIGHTMARE 45
323 RHINITIS ALLERGIC 45
324 HYPOTHYROIDISM 44
325 JOINT INJURY 44
326 LIMB DISCOMFORT 44
327 PANIC ATTACK 44
328 SPUTUM DISCOLOURED 44
329 SWOLLEN TONGUE 44
330 HIP FRACTURE 43
331 INJECTION SITE HAEMORRHAGE 43
332 INTERVERTEBRAL DISC DEGENERATION 43
333 LYMPHADENOPATHY 43
334 ROTATOR CUFF SYNDROME 43
335 DYSURIA 42
336 FOOD ALLERGY 42
337 RETCHING 42
338 SKIN FISSURES 42
339 VITAMIN D DEFICIENCY 42
340 MUSCULOSKELETAL DISCOMFORT 41
341 OSTEOPENIA 41
342 SCIATICA 41
343 UNDERDOSE 41
344 URINARY INCONTINENCE 41
345 ACNE 40
346 DEAFNESS 40
347 DERMATITIS 40
348 HYPOKALAEMIA 40
349 INJECTION SITE MASS 40
350 LOCALISED INFECTION 40
351 LOWER RESPIRATORY TRACT INFECTION 40
352 NEOPLASM MALIGNANT 40
353 NEUTROPENIA 40
354 BACK DISORDER 39
355 DEVICE DELIVERY SYSTEM ISSUE 39
356 EXTRA DOSE ADMINISTERED 39
357 EYE DISCHARGE 39
358 EYE INFECTION 39
359 GENERAL PHYSICAL HEALTH DETERIORATION 39
360 NEPHROGENIC ANAEMIA 39
361 POOR QUALITY SLEEP 39
362 RESTLESS LEGS SYNDROME 39
363 SPINAL OPERATION 39
364 TOOTH INFECTION 39
365 ANOSMIA 38
366 DRUG DEPENDENCE 38
367 EAR DISCOMFORT 38
368 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38
369 INFUSION SITE EXTRAVASATION 38
370 PHOTOPHOBIA 38
371 PROCEDURAL PAIN 38
372 PRODUCT DISTRIBUTION ISSUE 38
373 RHINITIS 38
374 THERAPEUTIC PRODUCT EFFECT DECREASED 38
375 ALANINE AMINOTRANSFERASE INCREASED 37
376 BACTERIAL INFECTION 37
377 DEEP VEIN THROMBOSIS 37
378 EATING DISORDER 37
379 INJECTION SITE URTICARIA 37
380 INTESTINAL OBSTRUCTION 37
381 OCULAR DISCOMFORT 37
382 THROMBOCYTOPENIA 37
383 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 37
384 BLOOD CREATININE INCREASED 36
385 CARDIAC ARREST 36
386 CYSTIC FIBROSIS 36
387 EXPOSURE DURING PREGNANCY 36
388 GLAUCOMA 36
389 GOUT 36
390 HAEMATOCHEZIA 36
391 HEAD DISCOMFORT 36
392 INCORRECT PRODUCT ADMINISTRATION DURATION 36
393 INCREASED TENDENCY TO BRUISE 36
394 KNEE ARTHROPLASTY 36
395 MUSCULOSKELETAL PAIN 36
396 TREATMENT NONCOMPLIANCE 36
397 UPPER LIMB FRACTURE 36
398 LABORATORY TEST ABNORMAL 35
399 LIP SWELLING 35
400 MULTIPLE SCLEROSIS 35
401 OROPHARYNGEAL DISCOMFORT 35
402 OVERDOSE 35
403 PAIN IN JAW 35
404 RENAL INJURY 35
405 SKIN LACERATION 35
406 SPINAL FRACTURE 35
407 THIRST 35
408 ACUTE RESPIRATORY FAILURE 34
409 DYSKINESIA 34
410 DYSSTASIA 34
411 GASTROINTESTINAL INFECTION 34
412 INJURY 34
413 LARYNGITIS 34
414 ORAL PAIN 34
415 SKIN INFECTION 34
416 ASPARTATE AMINOTRANSFERASE INCREASED 33
417 CARDIAC FAILURE 33
418 COVID-19 PNEUMONIA 33
419 DECREASED ACTIVITY 33
420 DIPLOPIA 33
421 DIZZINESS POSTURAL 33
422 EXPIRED PRODUCT ADMINISTERED 33
423 HEPATIC STEATOSIS 33
424 NASAL DRYNESS 33
425 NASAL POLYPS 33
426 PHARYNGITIS 33
427 PRODUCT CONTAINER ISSUE 33
428 SKIN BURNING SENSATION 33
429 TOOTH DISORDER 33
430 TYPE 2 DIABETES MELLITUS 33
431 URINARY RETENTION 33
432 ARRHYTHMIA 32
433 COLITIS 32
434 DISABILITY 32
435 DISORIENTATION 32
436 FREQUENT BOWEL MOVEMENTS 32
437 GLYCOSYLATED HAEMOGLOBIN INCREASED 32
438 RESTLESSNESS 32
439 THYROID DISORDER 32
440 BLOOD PRESSURE FLUCTUATION 31
441 BODY HEIGHT DECREASED 31
442 DRY THROAT 31
443 DYSARTHRIA 31
444 HAEMORRHOIDS 31
445 MALIGNANT NEOPLASM PROGRESSION 31
446 OBESITY 31
447 ORAL CANDIDIASIS 31
448 PULMONARY OEDEMA 31
449 WEIGHT FLUCTUATION 31
450 CARPAL TUNNEL SYNDROME 30
451 CHOKING 30
452 CROHN^S DISEASE 30
453 FULL BLOOD COUNT DECREASED 30
454 INCORRECT DRUG ADMINISTRATION RATE 30
455 MENTAL DISORDER 30
456 NERVE COMPRESSION 30
457 PERICARDIAL EFFUSION 30
458 PULMONARY HYPERTENSION 30
459 SKIN LESION 30
460 WOUND 30
461 DRUG EFFECT INCOMPLETE 29
462 DRUG EFFECT LESS THAN EXPECTED 29
463 ECONOMIC PROBLEM 29
464 HERNIA 29
465 MATERNAL EXPOSURE DURING PREGNANCY 29
466 PARANASAL SINUS DISCOMFORT 29
467 RECTAL HAEMORRHAGE 29
468 RIB FRACTURE 29
469 SCAR 29
470 SKIN IRRITATION 29
471 SNORING 29
472 TENDERNESS 29
473 ABNORMAL DREAMS 28
474 ANKLE FRACTURE 28
475 APHASIA 28
476 BLOOD IRON DECREASED 28
477 BRONCHIECTASIS 28
478 CHROMATURIA 28
479 DEVICE INFUSION ISSUE 28
480 EMPHYSEMA 28
481 HORDEOLUM 28
482 HYPOAESTHESIA ORAL 28
483 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 28
484 ORTHOSTATIC HYPOTENSION 28
485 PAIN OF SKIN 28
486 PHARYNGEAL SWELLING 28
487 PLASMA CELL MYELOMA 28
488 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28
489 SARS-COV-2 TEST POSITIVE 28
490 SINUS HEADACHE 28
491 BONE DENSITY DECREASED 27
492 BURSITIS 27
493 CHOLELITHIASIS 27
494 EXOSTOSIS 27
495 GASTRIC DISORDER 27
496 HYPERLIPIDAEMIA 27
497 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 27
498 JOINT STIFFNESS 27
499 LIGAMENT SPRAIN 27
500 PANCREATITIS 27
501 RESPIRATION ABNORMAL 27
502 RESPIRATORY FAILURE 27
503 SINUS OPERATION 27
504 SKIN HAEMORRHAGE 27
505 TOOTHACHE 27
506 GASTRITIS 26
507 HAEMATOCRIT DECREASED 26
508 HYPOPHAGIA 26
509 INABILITY TO AFFORD MEDICATION 26
510 INCREASED APPETITE 26
511 LEUKOCYTOSIS 26
512 LIVER DISORDER 26
513 LIVER FUNCTION TEST INCREASED 26
514 PARAESTHESIA ORAL 26
515 POST PROCEDURAL COMPLICATION 26
516 SKIN SWELLING 26
517 TUBULOINTERSTITIAL NEPHRITIS 26
518 WRIST FRACTURE 26
519 BREAST CANCER 25
520 CONTRAINDICATED PRODUCT ADMINISTERED 25
521 CRYING 25
522 DEMENTIA 25
523 EOSINOPHIL COUNT INCREASED 25
524 HYPOGLYCAEMIA 25
525 INITIAL INSOMNIA 25
526 MOOD ALTERED 25
527 PRODUCT PHYSICAL ISSUE 25
528 RESPIRATORY DISTRESS 25
529 SKIN ULCER 25
530 SPINAL OSTEOARTHRITIS 25
531 TENDONITIS 25
532 ARTHROPOD BITE 24
533 BLINDNESS 24
534 CYST 24
535 FEELING COLD 24
536 HEART RATE IRREGULAR 24
537 HYPONATRAEMIA 24
538 INFUSION SITE MASS 24
539 PARANASAL SINUS HYPERSECRETION 24
540 PHOTOSENSITIVITY REACTION 24
541 POOR VENOUS ACCESS 24
542 PULMONARY FIBROSIS 24
543 SEDATION 24
544 SHOCK 24
545 BASAL CELL CARCINOMA 23
546 COMPLICATION ASSOCIATED WITH DEVICE 23
547 DEVICE USE ISSUE 23
548 FACIAL PAIN 23
549 HEPATIC FUNCTION ABNORMAL 23
550 HOSPICE CARE 23
551 MALIGNANT MELANOMA 23
552 MUSCLE TIGHTNESS 23
553 NASAL SEPTUM DEVIATION 23
554 NEUTROPHIL COUNT DECREASED 23
555 POST PROCEDURAL INFECTION 23
556 PSEUDOMONAS INFECTION 23
557 RASH PAPULAR 23
558 RHINALGIA 23
559 SYSTEMIC LUPUS ERYTHEMATOSUS 23
560 ANGIOEDEMA 22
561 BLOOD ALKALINE PHOSPHATASE INCREASED 22
562 BRADYCARDIA 22
563 FAECES DISCOLOURED 22
564 IMMUNODEFICIENCY 22
565 INCONTINENCE 22
566 MOOD SWINGS 22
567 NERVOUS SYSTEM DISORDER 22
568 OBSTRUCTION 22
569 OBSTRUCTIVE SLEEP APNOEA SYNDROME 22
570 PERIORBITAL SWELLING 22
571 PNEUMONITIS 22
572 PRODUCT AVAILABILITY ISSUE 22
573 SKIN CANCER 22
574 VITAMIN D DECREASED 22
575 AUTOIMMUNE DISORDER 21
576 CORONARY ARTERY DISEASE 21
577 DEVICE DISLOCATION 21
578 FEEDING DISORDER 21
579 GASTRIC ULCER 21
580 IMMUNE SYSTEM DISORDER 21
581 MENISCUS INJURY 21
582 MIDDLE EAR EFFUSION 21
583 MOUTH ULCERATION 21
584 MUSCULOSKELETAL CHEST PAIN 21
585 ORAL DISCOMFORT 21
586 PARKINSON^S DISEASE 21
587 PHARYNGEAL OEDEMA 21
588 PRESYNCOPE 21
589 PRODUCT ADMINISTRATION ERROR 21
590 RHABDOMYOLYSIS 21
591 SPINAL DISORDER 21
592 TOOTH ABSCESS 21
593 ABDOMINAL PAIN LOWER 20
594 ABNORMAL BEHAVIOUR 20
595 ACCIDENTAL OVERDOSE 20
596 CHOLECYSTECTOMY 20
597 DEVICE RELATED INFECTION 20
598 DRUG EFFECT DECREASED 20
599 ENCEPHALOPATHY 20
600 ERYTHEMA OF EYELID 20
601 FEELING DRUNK 20
602 FEELING JITTERY 20
603 FOREIGN BODY SENSATION IN EYES 20
604 GLUCOSE TOLERANCE IMPAIRED 20
605 HYSTERECTOMY 20
606 INJECTION SITE DISCOLOURATION 20
607 MENTAL STATUS CHANGES 20
608 MUSCULOSKELETAL DISORDER 20
609 NEPHROPATHY 20
610 PNEUMONIA BACTERIAL 20
611 PNEUMOTHORAX 20
612 PRODUCT PREPARATION ERROR 20
613 PROSTATIC SPECIFIC ANTIGEN INCREASED 20
614 PRURITUS GENERALISED 20
615 PULMONARY CONGESTION 20
616 ULCER 20
617 VITREOUS FLOATERS 20
618 AGGRESSION 19
619 BIPOLAR DISORDER 19
620 BLOOD GLUCOSE ABNORMAL 19
621 BLOOD MAGNESIUM DECREASED 19
622 BLOOD URINE PRESENT 19
623 BODY TEMPERATURE INCREASED 19
624 DEVICE DIFFICULT TO USE 19
625 DEVICE FAILURE 19
626 ERUCTATION 19
627 FEBRILE NEUTROPENIA 19
628 GLOSSODYNIA 19
629 HEPATOMEGALY 19
630 IMPAIRED HEALING 19
631 INFUSION SITE RASH 19
632 LOWER LIMB FRACTURE 19
633 OXYGEN SATURATION ABNORMAL 19
634 PANCYTOPENIA 19
635 PAROSMIA 19
636 PETECHIAE 19
637 PLATELET COUNT INCREASED 19
638 PULMONARY FUNCTION TEST DECREASED 19
639 TOOTH FRACTURE 19
640 WITHDRAWAL SYNDROME 19
641 ABORTION SPONTANEOUS 18
642 ACUTE SINUSITIS 18
643 ANGER 18
644 BLEPHARITIS 18
645 BRONCHOSPASM 18
646 COLITIS ULCERATIVE 18
647 CONCUSSION 18
648 DEPRESSED LEVEL OF CONSCIOUSNESS 18
649 ERECTILE DYSFUNCTION 18
650 FAECES SOFT 18
651 HAEMATOMA 18
652 HALLUCINATION, VISUAL 18
653 HUNGER 18
654 HYPERTONIC BLADDER 18
655 IMPAIRED WORK ABILITY 18
656 INTERSTITIAL LUNG DISEASE 18
657 MACULAR DEGENERATION 18
658 MUSCLE TWITCHING 18
659 NOCTURIA 18
660 PALLOR 18
661 QUALITY OF LIFE DECREASED 18
662 REBOUND ACID HYPERSECRETION 18
663 SINUS PAIN 18
664 SMALL INTESTINAL OBSTRUCTION 18
665 SWELLING OF EYELID 18
666 TEMPERATURE INTOLERANCE 18
667 THERAPY CHANGE 18
668 ANAL INCONTINENCE 17
669 BLOOD CALCIUM DECREASED 17
670 DENTAL CARIES 17
671 DEVICE OCCLUSION 17
672 EYELID PAIN 17
673 HEPATIC CIRRHOSIS 17
674 INCORRECT DOSE ADMINISTERED BY DEVICE 17
675 INFUSION SITE DISCOMFORT 17
676 JAW DISORDER 17
677 PERIPHERAL COLDNESS 17
678 POSTOPERATIVE WOUND INFECTION 17
679 PSYCHOMOTOR HYPERACTIVITY 17
680 PSYCHOTIC DISORDER 17
681 SALIVARY HYPERSECRETION 17
682 SENSATION OF FOREIGN BODY 17
683 APATHY 16
684 ATELECTASIS 16
685 BLOOD TEST ABNORMAL 16
686 BLOOD THYROID STIMULATING HORMONE INCREASED 16
687 CHOKING SENSATION 16
688 CLOSTRIDIUM DIFFICILE INFECTION 16
689 DRUG DOSE OMISSION BY DEVICE 16
690 ENURESIS 16
691 EYE INFLAMMATION 16
692 FACIAL PARALYSIS 16
693 FEAR 16
694 GALLBLADDER DISORDER 16
695 GINGIVAL BLEEDING 16
696 HIP ARTHROPLASTY 16
697 HYPERPARATHYROIDISM SECONDARY 16
698 HYPERTHYROIDISM 16
699 INJECTION SITE DISCOMFORT 16
700 INJECTION SITE VESICLES 16
701 LIVER FUNCTION TEST ABNORMAL 16
702 PERIPHERAL VENOUS DISEASE 16
703 POST-TRAUMATIC STRESS DISORDER 16
704 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 16
705 PRECANCEROUS CONDITION 16
706 REGURGITATION 16
707 SJOGREN^S SYNDROME 16
708 SPINAL STENOSIS 16
709 THROAT CLEARING 16
710 TOXICITY TO VARIOUS AGENTS 16
711 TRANSFUSION 16
712 TRIGGER FINGER 16
713 ANIMAL BITE 15
714 ARTERIOSCLEROSIS 15
715 BLOOD BILIRUBIN INCREASED 15
716 BLOOD CALCIUM INCREASED 15
717 BLOOD COUNT ABNORMAL 15
718 CARDIAC FLUTTER 15
719 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 15
720 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15
721 EAR DISORDER 15
722 EMOTIONAL DISORDER 15
723 FEAR OF INJECTION 15
724 FEMUR FRACTURE 15
725 FULL BLOOD COUNT ABNORMAL 15
726 GINGIVAL PAIN 15
727 HEPATIC FAILURE 15
728 HYPOKINESIA 15
729 INFUSION SITE REACTION 15
730 INFUSION SITE URTICARIA 15
731 INTERNAL HAEMORRHAGE 15
732 INTRAOCULAR PRESSURE INCREASED 15
733 LUNG NEOPLASM MALIGNANT 15
734 MAJOR DEPRESSION 15
735 MASS 15
736 MENTAL IMPAIRMENT 15
737 MULTIPLE FRACTURES 15
738 OSTEOMYELITIS 15
739 PNEUMONIA ASPIRATION 15
740 PULMONARY ARTERIAL HYPERTENSION 15
741 RAYNAUD^S PHENOMENON 15
742 RENAL FAILURE ACUTE 15
743 RESPIRATORY ARREST 15
744 RHINOVIRUS INFECTION 15
745 ROSACEA 15
746 SKIN ABRASION 15
747 SLUGGISHNESS 15
748 SPUTUM PURULENT 15
749 SUICIDE ATTEMPT 15
750 SUPRAVENTRICULAR TACHYCARDIA 15
751 VAGINAL HAEMORRHAGE 15
752 ADRENAL INSUFFICIENCY 14
753 ATYPICAL PNEUMONIA 14
754 BLOOD POTASSIUM INCREASED 14
755 BONE DEMINERALISATION 14
756 C-REACTIVE PROTEIN INCREASED 14
757 CARDIAC OPERATION 14
758 CARDIO-RESPIRATORY ARREST 14
759 CHOLECYSTITIS 14
760 COLD SWEAT 14
761 EPILEPSY 14
762 ESSENTIAL HYPERTENSION 14
763 FLUID OVERLOAD 14
764 FOOD POISONING 14
765 HAND FRACTURE 14
766 HEART RATE ABNORMAL 14
767 INFUSION SITE INDURATION 14
768 INFUSION SITE IRRITATION 14
769 KNEE OPERATION 14
770 MACULOPATHY 14
771 MICTURITION URGENCY 14
772 NEOPLASM PROGRESSION 14
773 NERVE INJURY 14
774 PARANOIA 14
775 PLEURISY 14
776 PRODUCT COMPLAINT 14
777 PRODUCT PACKAGING ISSUE 14
778 PRODUCT PRESCRIBING ISSUE 14
779 PROLONGED EXPIRATION 14
780 PULMONARY THROMBOSIS 14
781 RENAL CYST 14
782 SENSORY DISTURBANCE 14
783 SKIN WEEPING 14
784 TONSILLITIS 14
785 TOOTH LOSS 14
786 APPENDICITIS 13
787 ASTHENOPIA 13
788 BACK INJURY 13
789 BLEPHAROSPASM 13
790 BLOOD CREATINE PHOSPHOKINASE INCREASED 13
791 BLOOD TRIGLYCERIDES INCREASED 13
792 BONE DISORDER 13
793 BOWEL MOVEMENT IRREGULARITY 13
794 CEREBRAL HAEMORRHAGE 13
795 CHORIORETINOPATHY 13
796 COORDINATION ABNORMAL 13
797 DEVICE USE ERROR 13
798 EAR PRURITUS 13
799 ENDOCRINE OPHTHALMOPATHY 13
800 EXERCISE TOLERANCE DECREASED 13
801 FRACTURE 13
802 GASTROINTESTINAL PAIN 13
803 GENERALISED OEDEMA 13
804 GROIN PAIN 13
805 HAIR TEXTURE ABNORMAL 13
806 HALLUCINATION, AUDITORY 13
807 HYPERGLYCAEMIA 13
808 HYPERKALAEMIA 13
809 INFUSION SITE NODULE 13
810 INFUSION SITE WARMTH 13
811 INJECTION SITE WARMTH 13
812 INTERNATIONAL NORMALISED RATIO INCREASED 13
813 LEUKAEMIA 13
814 LIBIDO DECREASED 13
815 MEDICATION ERROR 13
816 MUSCLE ATROPHY 13
817 MUSCLE STRAIN 13
818 MYASTHENIA GRAVIS 13
819 NASAL PRURITUS 13
820 NEOPLASM 13
821 NODULE 13
822 PAPULE 13
823 PERICARDITIS 13
824 PNEUMONIA PSEUDOMONAL 13
825 PRESCRIBED UNDERDOSE 13
826 PRODUCT CONTAINER SEAL ISSUE 13
827 PROSTATE CANCER 13
828 PSYCHIATRIC SYMPTOM 13
829 SEPTIC SHOCK 13
830 SKIN MASS 13
831 STREPTOCOCCAL INFECTION 13
832 THERMAL BURN 13
833 THINKING ABNORMAL 13
834 TONGUE DISCOMFORT 13
835 VENTRICULAR EXTRASYSTOLES 13
836 WALKING AID USER 13
837 ALLERGIC SINUSITIS 12
838 ANKYLOSING SPONDYLITIS 12
839 ARTERIOSCLEROSIS CORONARY ARTERY 12
840 ATRIAL FLUTTER 12
841 BLADDER DISORDER 12
842 BLOOD IMMUNOGLOBULIN G DECREASED 12
843 BRUXISM 12
844 CARDIAC MURMUR 12
845 CHEILITIS 12
846 CONJUNCTIVITIS ALLERGIC 12
847 DIASTOLIC DYSFUNCTION 12
848 EYELID MARGIN CRUSTING 12
849 EYELID PTOSIS 12
850 FLANK PAIN 12
851 FOOT OPERATION 12
852 GASTRIC INFECTION 12
853 GINGIVAL SWELLING 12
854 HAIR COLOUR CHANGES 12
855 HEMIPARESIS 12
856 HYPERPHAGIA 12
857 INFUSION SITE DISCOLOURATION 12
858 INJECTION SITE DISCHARGE 12
859 INJECTION SITE INDURATION 12
860 IRON DEFICIENCY ANAEMIA 12
861 LIQUID PRODUCT PHYSICAL ISSUE 12
862 LUNG INFECTION 12
863 LYMPHOCYTE COUNT DECREASED 12
864 OXYGEN CONSUMPTION INCREASED 12
865 PLANTAR FASCIITIS 12
866 POLYP 12
867 POST-ACUTE COVID-19 SYNDROME 12
868 PRODUCT PRESCRIBING ERROR 12
869 SENSITIVITY TO WEATHER CHANGE 12
870 SINUSITIS BACTERIAL 12
871 SKIN ATROPHY 12
872 SOMNAMBULISM 12
873 SUSPECTED COVID-19 12
874 TEMPOROMANDIBULAR JOINT SYNDROME 12
875 TENSION HEADACHE 12
876 TOOTH EXTRACTION 12
877 VASCULITIS 12
878 ABSCESS 11
879 ACTIVITIES OF DAILY LIVING IMPAIRED 11
880 ALLERGY TO ANIMAL 11
881 ARTHRITIS INFECTIVE 11
882 BACTERAEMIA 11
883 BLOOD UREA INCREASED 11
884 BRAIN NEOPLASM 11
885 BREATH SOUNDS ABNORMAL 11
886 CARDIAC PACEMAKER INSERTION 11
887 COMA 11
888 CONCOMITANT DISEASE AGGRAVATED 11
889 DEAFNESS NEUROSENSORY 11
890 DERMATITIS ALLERGIC 11
891 DIVERTICULUM INTESTINAL 11
892 DRUG ADMINISTRATION ERROR 11
893 DRUG ERUPTION 11
894 DYSPNOEA AT REST 11
895 EXTRASYSTOLES 11
896 EYE HAEMORRHAGE 11
897 GINGIVITIS 11
898 GRAVES^ DISEASE 11
899 HAEMATURIA 11
900 HEART VALVE INCOMPETENCE 11
901 HEPATIC CYTOLYSIS 11
902 HUMERUS FRACTURE 11
903 HYPERCHOLESTEROLAEMIA 11
904 HYPOSMIA 11
905 IMPAIRED DRIVING ABILITY 11
906 INCREASED UPPER AIRWAY SECRETION 11
907 JOINT RANGE OF MOTION DECREASED 11
908 LARGE INTESTINE POLYP 11
909 MANIA 11
910 MAST CELL ACTIVATION SYNDROME 11
911 MELAENA 11
912 MELANOCYTIC NAEVUS 11
913 MENINGITIS ASEPTIC 11
914 MOVEMENT DISORDER 11
915 MUSCLE SPASTICITY 11
916 NAIL DISORDER 11
917 NASAL TURBINATE HYPERTROPHY 11
918 OESOPHAGEAL ULCER 11
919 ONYCHOCLASIS 11
920 ONYCHOMYCOSIS 11
921 PRODUCT SOLUBILITY ABNORMAL 11
922 PSYCHOLOGICAL TRAUMA 11
923 SCLERODERMA 11
924 SHOULDER OPERATION 11
925 SKIN DISCOMFORT 11
926 SPINAL FUSION SURGERY 11
927 SQUAMOUS CELL CARCINOMA 11
928 THERAPEUTIC PRODUCT INEFFECTIVE 11
929 TRIGEMINAL NEURALGIA 11
930 UPPER GASTROINTESTINAL HAEMORRHAGE 11
931 VITAMIN B12 DEFICIENCY 11
932 ANAPHYLACTIC SHOCK 10
933 APHTHOUS ULCER 10
934 APPLICATION SITE PAIN 10
935 APPLICATION SITE PRURITUS 10
936 ATRIOVENTRICULAR BLOCK 10
937 BODY TEMPERATURE ABNORMAL 10
938 BREAST MASS 10
939 CHOLESTASIS 10
940 COELIAC DISEASE 10
941 CONJUNCTIVAL HAEMORRHAGE 10
942 DEAFNESS UNILATERAL 10
943 DECREASED INTEREST 10
944 DEVICE PROGRAMMING ERROR 10
945 DROOLING 10
946 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10
947 DRUG TITRATION ERROR 10
948 DRUG WITHDRAWAL SYNDROME 10
949 EAR CONGESTION 10
950 EAR SWELLING 10
951 ELECTROLYTE IMBALANCE 10
952 ENDOMETRIOSIS 10
953 FAECES HARD 10
954 FORMICATION 10
955 GESTATIONAL DIABETES 10
956 GLOMERULAR FILTRATION RATE DECREASED 10
957 HAEMATEMESIS 10
958 HELICOBACTER GASTRITIS 10
959 HERPES SIMPLEX 10
960 INFUSION SITE INFECTION 10
961 INJECTION SITE NODULE 10
962 JAUNDICE 10
963 LIPOMA 10
964 LOW DENSITY LIPOPROTEIN INCREASED 10
965 LYMPHOMA 10
966 MADAROSIS 10
967 MYCOTIC ALLERGY 10
968 ORAL MUCOSAL BLISTERING 10
969 PARKINSONISM 10
970 PELVIC PAIN 10
971 PERIORBITAL PAIN 10
972 PIGMENTATION DISORDER 10
973 PNEUMONIA INFLUENZAL 10
974 POOR QUALITY DEVICE USED 10
975 PRESCRIBED OVERDOSE 10
976 PRODUCT ADHESION ISSUE 10
977 PRODUCT DISPENSING ERROR 10
978 PRODUCT SUPPLY ISSUE 10
979 PROSTATOMEGALY 10
980 PROTEINURIA 10
981 RALES 10
982 REBOUND EFFECT 10
983 RECALLED PRODUCT ADMINISTERED 10
984 SCRATCH 10
985 SENSITIVE SKIN 10
986 SINUS TACHYCARDIA 10
987 SKIN WARM 10
988 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 10
989 SPINAL COMPRESSION FRACTURE 10
990 SPONDYLITIS 10
991 SYRINGE ISSUE 10
992 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 10
993 TENDON RUPTURE 10
994 TIBIA FRACTURE 10
995 TROPONIN INCREASED 10
996 ULCER HAEMORRHAGE 10
997 UNRESPONSIVE TO STIMULI 10
998 UROSEPSIS 10
999 VASCULAR DEVICE INFECTION 10